ELEGEN
91 employees
Biotech
Growth · $35.0M
Open positions (5)
Company details
Team Size91
IndustryBiotech
Funding
Total raised
$35.0M
Last stage
Growth
Investors
Total raised
$35.0M
Last stage
Growth
Investors
Matt Hill
PhD from Stanford with a proven track record of advancing innovative technologies from invention to commercial success. Founded Elegen in 2017 to eliminate the DNA bottleneck at the core of synthetic biology applications.
Marc Unger
Inventor of the Nanoflex™ valve and former CSO of Fluidigm. Leading biotechnology scientist advising and staffed at Elegen.
Dan La Caze
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.